The management of locally advanced pancreatic cancer (LAPC) patients remains controversial. Better discrimination for the prediction of overall survival (OS) at baseline is needed to improve therapeutic decisions and optimize clinical trials design. We proposed a prognostic score and a nomogram to address this issue.

Ces outils de prediction sont conçus pour aider les médecins à prédire le profil de risque de son patient et son pronostic individuel dans le but d'apporter une aide dans le management clinique du patient. Ils peuvent également être utilisés par les chercheurs pour optimiser la conception des futurs essais cliniques et assurer un bon équilibre des bras d'étude en terme de profil de risque.   

Si vous êtes un patient, nous vous recommandons d'utiliser ces outils uniquement en consultation avec votre médecin.

A propos de Dewi VERNEREY


    Dewi Vernerey is a research engineer in epidemiology and biostatistics who received a master’s degree cum laude from Joseph Fourier University (Grenoble, France) with a major in  engineering statistics. He defended a PhD in epidemiology and statistics in 2016. His PhD research focused on statistical methodology for risk prediction and prognostic score construction in oncology and kidney transplantation.

A propos de Sophie PAGET-BAILLY


Sophie Paget-Bailly is a research engineer in epidemiology and clinical research. She passed with honours the East of France inter-region master’s degree in public health and occupational and environmental risks. During the master’s degree’s internship in the Interregional Epidemiology Unit of Bourgogne/Franche-Comté, she realized a quantitative health risk assessment in the context of chemical contamination of groundwater. She defended a PhD in Public Health and Epidemiology in Paris XI University, Doctoral School 420, working in the Centre for Research in Epidemiology and Population Health in Villejuif, France. During her PhD, she worked on occupational exposures and head and neck cancer, providing two systematic reviews and meta-analyses and analyzing data from the ICARE case-control study. She was also representative of the PhD students at the ED420 school council.

A propos de Franck BONNETAIN


Franck Bonnetain is a full Professor in epidemiology and biostatistics who received a master’s degree in clinical epidemiology from School of Public Health (Nancy, France). He obtained a PhD in public health with epidemiology and statistics specialties in 2005 as well asthe “Habilitation à diriger des recherches” (Professoral capability) in 2010. 

2015-2019 © Copyright - UMQVC.org

Website by Pearlweb